Selank vs Semax: Nootropic Peptides Guide 2026

Selank is a synthetic heptapeptide analog of tuftsin, and Semax is a synthetic heptapeptide analog of ACTH(4-10), the two most-studied compounds in the nootropic peptide category. Both were developed at the Russian Academy of Medical Sciences in the 1980s and 1990s and have been in clinical use in Russia for decades, Semax for stroke recovery and cognitive disorders, Selank for generalized anxiety. In the US research market, they are now among the most-requested compounds in the cognitive performance and stress-resilience research category.

This guide is the working 2026 reference: where each peptide came from, what the mechanisms actually are, what the trial and lab data show, how researchers dose them (intranasal vs subcutaneous), the side effect profile, how to choose between them, and a strict sourcing checklist for the US market.

For research and laboratory use only. Not medical advice.

Origin, Russian Neuropeptide Engineering

Both Selank and Semax are synthetic heptapeptides engineered from naturally occurring human regulatory peptides:

• •Semax = ACTH(4-10) fragment with a Pro-Gly-Pro tail added at the C-terminus. The ACTH(4-10) sequence is the neurotrophic core of adrenocorticotropic hormone, stripped of the stress-axis activity. The Pro-Gly-Pro tail dramatically extends half-life from minutes to hours by resisting peptidase cleavage.
• •Selank = a synthetic analog of tuftsin (a natural immunomodulatory peptide), with the same Pro-Gly-Pro stabilization tail.

The Pro-Gly-Pro design philosophy is the signature of the Russian neuropeptide program. Take a biologically active short peptide, stabilize it against enzymatic degradation, and turn it into a usable research compound.

Mechanism, How They Actually Work

The two peptides share the family origin but diverge sharply at the receptor and neurochemistry level.

Semax Mechanism

Semax acts on multiple pathways simultaneously:

1. BDNF and NGF upregulation, Semax is one of the most consistent BDNF-inducing small peptides in the published literature, with hippocampal BDNF/trkB expression changes documented directly in animal models.(1) BDNF (brain-derived neurotrophic factor) is the central driver of synaptic plasticity and long-term cognitive performance.
2. Dopaminergic and serotonergic modulation, Semax increases dopamine and serotonin turnover in cortical regions, contributing to its alerting and mood effects.
3. Neuroprotection, Strong evidence in ischemia models for reduction of infarct size and improved recovery, which is the basis of its Russian stroke indication.
4. Enkephalin enhancement, Semax inhibits enkephalin breakdown, contributing to analgesic and anti-stress effects.

The net research subject experience is described as focused alertness with reduced cognitive fatigue, clearer thinking under load rather than the jittery stimulation of caffeine.

Selank Mechanism

Selank acts on a different axis:

1. GABAergic modulation, Selank potentiates GABA-A receptor signaling indirectly, producing an anxiolytic effect comparable in published Russian trials to benzodiazepines like medazepam, without sedation, tolerance, or withdrawal, animal studies have shown Selank enhances the anxiolytic effect of diazepam under chronic stress conditions.(2)
2. Serotonergic upregulation, Selank increases brain serotonin levels and 5-HT turnover, contributing to mood stabilization.
3. BDNF upregulation, Like Semax, Selank also raises BDNF, though the magnitude is more modest.
4. Immune modulation, Inherited from tuftsin, Selank has documented immunomodulatory effects, particularly on interferon and Th1/Th2 balance.

The net research subject experience is described as calm clarity, reduced anxiety and stress reactivity without sedation or cognitive dulling.

Side-by-Side Mechanism Comparison

This is why researchers treat the two as complementary, not interchangeable. Semax is the "do" peptide. Selank is the "calm" peptide.

What the Research Shows

Semax Evidence

• •Stroke recovery: Multiple Russian trials show improved functional recovery scores in ischemic stroke subjects when Semax is added to standard care within 24 hours of event onset
• •ADHD: Pediatric trials in Russia have shown attention and behavioral improvements at intranasal doses of 50 to 100 mcg/kg
• •Cognitive performance: Healthy-subject studies show improvements on attention and memory tasks, with effect sizes comparable to mild stimulants but without the cardiovascular signature
• •BDNF: Animal models show robust, dose-dependent BDNF increases in hippocampus and cortex within hours of administration
• •Neuroprotection: Reduced infarct volume, reduced oxidative stress markers, improved neurogenesis in ischemia models

Selank Evidence

• •Generalized anxiety disorder: Russian phase 3 trials showed efficacy comparable to medazepam at intranasal doses of 250 to 500 mcg per administration, without sedation or dependence
• •Stress reactivity: Reduction in cortisol response to laboratory stressors
• •Cognitive performance under stress: Maintenance of attention and working memory when subjects are exposed to stressors that normally degrade performance
• •BDNF: Documented increases, though smaller than Semax
• •Immune effects: Modulation of cytokine profiles, particularly interferon-gamma upregulation

The Russian literature on both compounds is more substantial than Western researchers often realize. Translated and indexed studies date back to the 1990s.

Dosing Parameters Reported in the Literature

Both compounds are most commonly studied via intranasal administration because of brain access through the cribriform plate, though subcutaneous administration is also documented in the literature. Published Russian clinical research and pilot studies report administration frequency and cycle-length parameters that vary by research question (cognitive performance vs. stroke recovery for Semax; generalized anxiety disorder research for Selank), consult the cited primary sources for the exact figures used in each study.

Reconstitution for Intranasal Research Use

Both compounds are typically supplied as lyophilized powder, commonly in 5 mg or 10 mg vials. See our reconstitution concentration reference for the general mg/mL formula. For intranasal research applications, the reconstituted solution is typically transferred to a sterile calibrated nasal spray bottle.

Storage

• •Lyophilized: 24+ months at minus 20 C, 6 to 12 months refrigerated
• •Reconstituted in bacteriostatic water: 4 weeks at 2 to 8 C
• •Reconstituted in nasal spray bottle: Same 4-week window; protect from light
• •Do not freeze reconstituted solution

Side Effects, The Real Profile

Both Selank and Semax have remarkably clean side effect profiles in the published literature. This is one of the reasons they have remained in continuous clinical use in Russia for decades.

Semax:

• •Mild headache in a small percentage of subjects, usually first-dose only
• •Local nasal irritation with intranasal use, particularly at high concentrations
• •Rare reports of mild irritability at supra-therapeutic doses
• •No documented tolerance, dependence, or withdrawal

Selank:

• •Rare reports of mild headache
• •Local nasal irritation with intranasal use
• •No sedation (a notable advantage over benzodiazepines)
• •No documented tolerance, dependence, or withdrawal

What both compounds specifically do not show in the published literature:

• •No cardiovascular signal
• •No hepatotoxicity signal
• •No HPA-axis suppression
• •No abuse potential

The clean profile is part of the reason these compounds have crossed from Russian clinical practice into the global research peptide market.

Choosing Between Semax and Selank in Research Design

The choice maps to the research question:

• •Cognitive performance, focus, mental output under load → Semax
• •Anxiety, stress reactivity, sleep disruption from rumination → Selank
• •Stroke recovery, neuroprotection research → Semax
• •Acute stress research models → Selank
• •Sustained attention research models → Semax
• •SSRI-resistant low mood with anxiety component → Selank, often studied alongside standard-of-care research

Some research designs study the two in combination, Semax for cognitive-activation endpoints, Selank for stress-decompression endpoints. No interaction is documented, and the mechanisms are non-overlapping.

How Research Protocols Are Structured

Published cognitive-performance research on Semax and anxiolytic research on Selank generally follow a multi-week study period with defined assessment intervals (attention/memory batteries for Semax; standardized anxiety scales for Selank), followed by an off-cycle reassessment period. Some study designs examine the two peptides in combination across a similar multi-week structure. Consult the cited primary literature for exact published parameters.

Sourcing, The Checklist for Selank and Semax

Both peptides are short, well-defined sequences and are technically straightforward to synthesize at high purity, but the intranasal route raises the bar for impurity tolerance, because nasal mucosa is sensitive and impurities cause local irritation.

Demand for every vial:

1. Per-lot HPLC at 98 percent or higher (99 percent preferred for intranasal use)
2. Mass spec confirmation, Semax molecular weight is 813.94 Da; Selank is 751.86 Da
3. Net peptide content disclosed, not gross lyophilizate weight
4. Counter-ion percentage (TFA or acetate)
5. Endotoxin below 5 EU/mg (especially critical for intranasal use where the mucosa is permeable)
6. US warehouse shipping with appropriate handling
7. Vial lot number matching the COA

Avoid:

• •Vendors pricing 10 mg Semax or Selank below ~$30, almost certainly underfilled or impure
• •Vendors without third-party HPLC verification
• •Any vial without a lot number
• •Vendors selling "pre-mixed nasal sprays" of unknown concentration

Enlife Peptides ships Selank and Semax from the US warehouse with per-lot HPLC and MS COAs, third-party verified purity, honest net-peptide-content labeling, and cold-pack handling. Both compounds sit inside the benchmark price range for legitimate research-grade product.

Frequently Asked Questions

Are Selank and Semax FDA approved?

No. Both are approved as prescription drugs in Russia (Semax since 1982, Selank since 2009) but are not FDA-approved in the United States. They are sold strictly as research peptides for laboratory use and are not for human consumption.

Which is better, Selank or Semax?

Neither is universally better, they target different axes. Semax is for cognitive performance, focus and neuroprotection. Selank is for anxiety, stress reactivity and calm clarity. Research subjects asking the same question for both compounds are usually asking the wrong question, pick the peptide that matches the research endpoint.

Can I take Selank and Semax together?

There is no documented interaction and the mechanisms do not overlap. Some research protocols pair Semax AM with Selank PM. Run shorter cycles when stacking to better isolate effects.

Do Selank or Semax cause dependence?

No. Neither compound has documented tolerance, dependence, or withdrawal in the published literature, a notable advantage over benzodiazepines (for Selank's anxiolytic application) and over stimulants (for Semax's cognitive application).

Why intranasal instead of injection?

Both peptides cross the cribriform plate and reach brain tissue more efficiently via the intranasal route than via subcutaneous injection. Intranasal also avoids first-pass hepatic metabolism and is the route used in Russian clinical practice. Subcutaneous dosing is documented but less common.

How long until I see effects?

Subjective effects from a single intranasal dose are typically noticed within 30 to 60 minutes. The BDNF and structural effects build over a 7 to 14 day cycle. Most published research protocols run 14 to 30 days continuous before assessment.

Why buy Selank or Semax from Enlife Peptides?

US warehouse fulfillment, per-lot HPLC and MS COAs, third-party verification, honest net-peptide-content labeling, cold-pack shipping, and pricing inside the legitimate benchmark range. Run the sourcing checklist in this guide against any vendor, Enlife passes it.

Bottom Line

Selank and Semax are the two most-researched nootropic peptides on the modern market, with decades of Russian clinical data behind them and remarkably clean side effect profiles. They are not interchangeable, Semax drives cognitive performance, focus, and BDNF-mediated neuroplasticity; Selank delivers calm clarity, anxiolysis, and stress resilience. For a serious research program in cognitive performance or stress resilience, both compounds belong in the working library.

References

1. Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006 Oct 30;1117(1):54-60. PMID: 16996037.
2. Kolyasnikova KN, Nadorova AV, Sazonova NM, Poletaeva II, Kost NV. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behav Neurol. 2017;2017:9268270. PMID: 28280289.

For research and laboratory use only. Not for human consumption.